AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

55.19
Delayed Data
As of Mar 26
 +1.18 / +2.18%
Today’s Change
16.49
Today|||52-Week Range
59.03
+29.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. It focused on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron deficiency anemia or IDA. The company engages in manufacture, development and commercialization of products derived from its proprietary technology for use in treating human diseases. AMAG Pharmaceuticals was founded in November 1981 and is headquartered in Waltham, MA.

Contact Information

AMAG Pharmaceuticals, Inc.
1100 Winter Street
Waltham Massachusetts 02451
P:(617) 498-3300
Investor Relations:

Employees

Shareholders

Other institutional63.89%
Mutual fund holders41.46%
Individual stakeholders16.16%

Top Executives

William K. HeidenPresident, CEO & Executive Director
Frank E. ThomasChief Operating Officer & Executive Vice President
Scott A. HolmesTreasurer, CAO, SVP-Finance & Investor Relations
Scott T. McMillanSenior VP-Quality & Technical Operations
Robert KaperSenior Vice President-Medical & Scientific Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account